R. Nahar

CYP2C9, VKORC1, CYP4F2, ABCB1 and F5 variants: Influence on quality of long-term anticoagulation

R. Saxena, R. Deb, I. Verma, 2014, Pharmacological reports : PR.

Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity.

T. Singh, D. Dube, R. Saxena, 2013, Thrombosis research.

Variability in CYP2C9 allele frequency: A pilot study of its predicted impact on warfarin response among healthy South and North Indians

R. Saxena, R. Deb, I. Verma, 2013, Pharmacological reports : PR.

Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers

R. Saxena, R. Deb, I. Verma, 2012, Indian journal of human genetics.

Survival Analysis of Down Syndrome Cohort in a Tertiary Health Care Center in India

R. Pandey, I. Verma, R. Puri, 2013, The Indian Journal of Pediatrics.

Do parental perceptions and motivations towards genetic testing and prenatal diagnosis for deafness vary in different cultures?

R. Saxena, I. Verma, R. Puri, 2013, American journal of medical genetics. Part A.

Genetic Bleeding Risk Score (GBRS) for Patients on Oral Anticoagulant Therapy

R. Saxena, R. Deb, I. Verma, 2013 .

Genetic studies in Poland.

D. F. Roberts, N. Wolański, R. Nahar, 1983, Human heredity.